Global Auto-Injectors Market Growth 2025-2031

Global Auto-Injectors Market Growth 2025-2031

The global Auto-Injectors market size is predicted to grow from US$ 2540 million in 2025 to US$ 3981 million in 2031; it is expected to grow at a CAGR of 7.8% from 2025 to 2031.

Auto-injector is a medical device designed to deliver a dose of a particular drug.

Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.

Global Auto-Injectors key players include Mylan, BD, Johnson & Johnson, Amgen, Eli Lilly, etc. Global top five manufacturers hold a share over 70%.

North America is the largest market, with a share about 60%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.

In terms of product, Disposable Auto-Injectors is the largest segment, with a share over 60%. And in terms of application, the largest application is Anaphylaxis, followed by Multiple Sclerosis, Rheumatoid Arthritis, etc.

LP Information, Inc. (LPI) ' newest research report, the “Auto-Injectors Industry Forecast” looks at past sales and reviews total world Auto-Injectors sales in 2024, providing a comprehensive analysis by region and market sector of projected Auto-Injectors sales for 2025 through 2031. With Auto-Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Auto-Injectors industry.

This Insight Report provides a comprehensive analysis of the global Auto-Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Auto-Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Auto-Injectors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Auto-Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Auto-Injectors.

This report presents a comprehensive overview, market shares, and growth opportunities of Auto-Injectors market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Disposable Auto-Injectors
Reusable Auto-Injectors

Segmentation by Application:
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mylan
BD
Johnson & Johnson
Amgen Inc.
Eli Lilly
Biogen Idec
Bayer
Meridian (Pfizer)
Ypsomed Holding
Kaleo, Inc.
Owen Mumford
Antares Pharma, Inc.
Medeca Pharma AB

Key Questions Addressed in this Report

What is the 10-year outlook for the global Auto-Injectors market?

What factors are driving Auto-Injectors market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Auto-Injectors market opportunities vary by end market size?

How does Auto-Injectors break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.